Shares of Acasti Pharma (NASDAQ:ACST) are jumping more than 25% higher today after a major investment firm initiated coverage. ACST stock has declined by more than 50% year to date (YTD), vastly ...

Penny stock Acasti Pharma (NASDAQ:ACST) is not messing around today. Shares of the pharmaceutical play are up more than 100%! But without any company news, what is behind the move in ACST stock? And ...

Here is everything potential investors in ACST stock need to know as shares soar higher today. ACST stock was up 44.4% as of Monday morning. On the date of publication, William White did not have ...

Acasti Pharma (NASDAQ:ACST) is a classic example of the extreme volatility of small-cap biotech stocks. It was only in late December that the shares were fetching $2.87, up from $1 a year earlier. But ...

Canadian biopharma company Acasti Pharma (NASDAQ:ACST) said on Friday that it will effect a 1-for-6 reverse stock split to increase the company's per share market price and regain compliance with ...

Acasti Pharma (ACST) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one of the ...

Today, Oppenheimer initiated coverage on ACST stock with an “outperform” rating and a price target of $6. Even after today’s significant price increase, the price target still represents upside of ...